Industry Use of Abbreviated 510(k) Falling Short of Agency Expectations
This article was originally published in The Gray Sheet
Executive Summary
Industry fears over the possibility of automatic inspections of companies electing to follow the abbreviated 510(k) approval path are unfounded, FDA staffers maintain.